UBE2C Antibody - middle region: FITC (ARP43473_P050-FITC)

The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, ubiquitin-conjugating enzymes, and ubiquitin-protein ligases. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. The encoded protein is required for the destruction of mitotic cyclins and for cell cycle progression, and may be involved in cancer progression. Multiple transcript variants encoding different isoforms have been found for this gene. Pseudogenes of this gene have been defined on chromosomes 4, 14, 15, 18, and 19.

ANAPC11; FZR1; KLHL2; UBE2C; PCGF3; UBC; MAPK7; UBA1; BAG3; TNNC1; CXCR1; Rag1; TTC9C; UNK; ZFYVE19; UBQLN4; UBXN1; UBQLN1; UBXN7; TTLL12; SEC24A; AHCYL1; SSSCA1; YAP1; UBE4B; USP34; ZRANB2; ATP6V1F; USP9X; UBE2V1; UBE2B; TYMS; TRIP6; PSMC6; PSMA5; PPM1G

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.